Practical guide to the use of abiraterone in castration resistant prostate cancer

Practical guide to the use of abiraterone in castration resistant prostate cancer

ID:41219975

大小:209.71 KB

页数:7页

时间:2019-08-19

Practical guide to the use of abiraterone in castration resistant prostate cancer_第1页
Practical guide to the use of abiraterone in castration resistant prostate cancer_第2页
Practical guide to the use of abiraterone in castration resistant prostate cancer_第3页
Practical guide to the use of abiraterone in castration resistant prostate cancer_第4页
Practical guide to the use of abiraterone in castration resistant prostate cancer_第5页
资源描述:

《Practical guide to the use of abiraterone in castration resistant prostate cancer》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、PracticalguidetotheuseofabirateroneincastrationresistantprostatecancerElaheA.Mostaghel,MD,1,2DanielW.Lin,MD31DivisionofClinicalResearch,FredHutchinsonCancerResearchCenter,Seattle,Washington,USA2DivisionofMedicalOncology,UniversityofWashington,SeattleWashington,USA3DepartmentofUrology,UniversityofWa

2、shington,Seattle,Washington,USAMOSTAGHELEA,LINDW.Practicalguidetotheandmonitoringrequirements,andconcludebydiscussinguseofabirateroneincastrationresistantprostatefuturedirectionsintheuseofabiraterone,includingcancer.CanJUrol2014;21(Suppl1):57-63.earlydatasupportinganexpandedroleforabirateroneincast

3、rationsensitivedisease.Introduction:WhileandrogendeprivationtherapyResults:Accumulatingdataemphasizethat‘androgenremainstheprimarytreatmentmodalityforpatientswithindependent’or‘hormonerefractory’tumorsremainmetastaticprostatecancer,treatmentisuniformlymarkedsensitivetohormonalactivationandsuggestth

4、atdespitebyprogressiontocastrationresistantprostatecancersuppressionofcirculatingtestosterone(T),residualtumor(CRPC).AbirateroneisthefirstnewdrugtoenterclinicalandrogensplayaprominentroleinmediatingCRPCpracticeinaseriesofnovelagentsdesignedtopotentlyprogression.targetadrenalandtumorandrogenproducti

5、on.Conclusions:Accordingly,therapeuticstrategiessuchMaterialsandmethods:Herein,wereviewtheabirateronethatmoreeffectivelytargetproductionofmechanismofactionofabirateroneandthephaseIIIintratumoralandrogensarenecessary.datasupportingitsapprovalforpatientswithmetastaticCRPC.Wediscusspracticaltreatmentc

6、onsiderations,KeyWords:castrationresistantprostatecancer,includingtheincidenceandmanagementofsideeffectintratumoralandrogen,CYP17A,abirateroneIntroductionactivationandsuggestthatdespitesuppressionofcirculatingtestosterone(T),residualtumorandrogensTheefficacyofandrogendeprivationtherapy(ADT)isplayap

7、rominentroleinmediatingCRPCprogression.5routinelybasedonachievingcastratelevelsofserumT,EmergingdatasuggestresidualintratumoralandrogensarbitrarilydefinedasT≤20or50ng/dL.However,areproducedviatheuptakeandco

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。